Oliver Hucke
About
Oliver Hucke is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry.
According to data from OpenAlex, Oliver Hucke has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Infectious Diseases and 7 papers in Organic Chemistry. Recurrent topics in Oliver Hucke's work include HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (6 papers) and Malaria Research and Control (5 papers). Oliver Hucke is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Hepatitis C virus research (6 papers) and Malaria Research and Control (5 papers). Oliver Hucke collaborates with scholars based in Canada, Germany and United States. Oliver Hucke's co-authors include Paul Edwards, Steven R. LaPlante, Lee D. Fader, Araz Jakalian, Keith R. Fandrick, Ray Kemper, Daniel R. Fandrick, Stephen Miller, Christophe L. M. J. Verlinde and Michael H. Gelb and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Molecular Biology.
In The Last Decade
Oliver Hucke
30 papers receiving 1.8k citations
Hit Papers
Peers
Oliver Hucke
Andrea Tafi Italy
Steven R. LaPlante Canada
Lin Ai United States
Brad Sherborne United Kingdom
Marcelo Zaldini Hernandes Brazil
Carlos A. Montanari Brazil
Peter W. Kenny United Kingdom
K. Nagarajan India
Raman Sharma United States
Simona Golič Grdadolnik Slovenia
Citations per year, relative to Oliver Hucke Oliver Hucke (= 1×)
peers
Andrea Tafi
Countries citing papers authored by Oliver Hucke
Since
Specialization
Citations
This map shows the geographic impact of Oliver Hucke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Hucke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Hucke more than expected).
Fields of papers citing papers by Oliver Hucke
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Oliver Hucke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Hucke. The network helps show where Oliver Hucke may publish in the future.
Co-authorship network of co-authors of Oliver Hucke
This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Hucke. A scholar is included among the top collaborators of Oliver Hucke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Hucke. Oliver Hucke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Saleh, Noureldin, Oliver Hucke, Esther Schmidt, et al.. (2018). Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Angewandte Chemie. 130(10). 2610–2615.
2.
Fader, Lee D., Serge Landry, Sébastien Morin, et al.. (2013). Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: Addressing configurational instability through scaffold modification. Bioorganic & Medicinal Chemistry Letters. 23(11). 3396–3400.
3.
Goudreau, Nathalie, Oliver Hucke, Anne‐Marie Faucher, et al.. (2013). Discovery and Structural Characterization of a New Inhibitor Series of HIV-1 Nucleocapsid Function: NMR Solution Structure Determination of a Ternary Complex Involving a 2:1 Inhibitor/NC Stoichiometry. Journal of Molecular Biology. 425(11). 1982–1998.
4.
Spickler, Catherine, Julie Lippens, Michel Garneau, et al.. (2013). Phosphatidylinositol 4-Kinase III Beta Is Essential for Replication of Human Rhinovirus and Its Inhibition Causes a Lethal Phenotype In Vivo. Antimicrobial Agents and Chemotherapy. 57(7). 3358–3368.
5.
Beaulieu, Pierre L., René Coulombe, Jianmin Duan, et al.. (2013). Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype. Bioorganic & Medicinal Chemistry Letters. 23(14). 4132–4140.
6.
Sedykh, Alexander, Denis Fourches, Jianmin Duan, et al.. (2012). Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions. Pharmaceutical Research. 30(4). 996–1007.
7.
Tremblay, Martin, Pierre Bonneau, Yves Bousquet, et al.. (2012). Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold. Bioorganic & Medicinal Chemistry Letters. 22(24). 7512–7517.
8.
Lemke, Christopher T., Nathalie Goudreau, Songping Zhao, et al.. (2011). Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335. Journal of Biological Chemistry. 286(13). 11434–11443.
9.
LaPlante, Steven R., Lee D. Fader, Keith R. Fandrick, et al.. (2011). Assessing Atropisomer Axial Chirality in Drug Discovery and Development. Journal of Medicinal Chemistry. 54(20). 7005–7022.
10.
Böcker, Alexander, Pierre Bonneau, Oliver Hucke, Araz Jakalian, & Paul Edwards. (2010). Development of Specific “Drug‐Like Property” Rules for Carboxylate‐Containing Oral Drug Candidates. ChemMedChem. 5(12). 2102–2113.
11.
Voorhis, Wesley C. Van, Kasey Rivas, Laxman Nallan, et al.. (2007). Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein Farnesyltransferase. Antimicrobial Agents and Chemotherapy. 51(10). 3659–3671.
12.
Eastman, Richard T., John White, Oliver Hucke, et al.. (2006). Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase. Molecular and Biochemical Parasitology. 152(1). 66–71.
13.
Glenn, Matthew P., Oliver Hucke, Christophe L. M. J. Verlinde, et al.. (2005). Structurally Simple Farnesyltransferase Inhibitors Arrest the Growth of Malaria Parasites. Angewandte Chemie International Edition. 44(31). 4903–4906.
14.
Eastman, Richard T., John White, Oliver Hucke, et al.. (2005). Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum. Journal of Biological Chemistry. 280(14). 13554–13559.
15.
Hucke, Oliver, Michael H. Gelb, Christophe L. M. J. Verlinde, & Frederick S. Buckner. (2005). The Protein Farnesyltransferase Inhibitor Tipifarnib as a New Lead for the Development of Drugs against Chagas Disease. Journal of Medicinal Chemistry. 48(17). 5415–5418.
16.
Hucke, Oliver, Emile Schiltz, Gerhart Drews, & Andreas Labahn. (2003). Sequence analysis reveals new membrane anchor of reaction centre‐bound cytochromes possibly related to PufX. FEBS Letters. 535(1-3). 166–170.
17.
Siedle, Bettina, Ramón Murillo, Oliver Hucke, Andreas Labahn, & Irmgard Merfort. (2003). Structure activity relationship studies of cinnamic acid derivatives as inhibitors of human neutrophil elastase revealed by ligand docking calculations.. PubMed. 58(5). 337–9.
18.
Siedle, Bettina, Ramón Murillo, Vı́ctor Castro, et al.. (2002). Sesquiterpene lactones as inhibitors of human neutrophil elastase. Bioorganic & Medicinal Chemistry. 10(9). 2855–2861.
19.
Hucke, Oliver, Ralf Schmid, & Andreas Labahn. (2002). Exploring the primary electron acceptor (QA)‐site of the bacterial reaction center from Rhodobacter sphaeroides. European Journal of Biochemistry. 269(4). 1096–1108.
20.
Steinbrecher, Thomas, et al.. (2002). Binding affinities and protein ligand complex geometries of nucleotides at the F1 part of the mitochondrial ATP synthase obtained by ligand docking calculations. FEBS Letters. 530(1-3). 99–103.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Andrea Tafi Breakdown of academic impact, for papers by Steven R. LaPlante Breakdown of academic impact, for papers by Lin Ai Breakdown of academic impact, for papers by Brad Sherborne Breakdown of academic impact, for papers by Marcelo Zaldini Hernandes Breakdown of academic impact, for papers by Carlos A. Montanari Breakdown of academic impact, for papers by Peter W. Kenny Breakdown of academic impact, for papers by K. Nagarajan Breakdown of academic impact, for papers by Raman Sharma Breakdown of academic impact, for papers by Simona Golič Grdadolnik